FDA updates EUAs for COVID-19 antigen tests, alerts providers to device recall and shortage

Nov 02, 2022 - 04:01 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require updates to product labeling regarding serial testing. As recommended in August, the revised EUAs and labeling call for users with COVID-19 symptoms to repeat testing at least twice over three days and users without symptoms to repeat testing at least three times over five days, with at least 48 hours between tests.

In other news, the FDA yesterday designated the recall of 60,500 filters used in breathing systems a Class I recall, meaning the devices may cause serious injury or death. Teleflex recalled the Iso-Gard S filters in August. On Monday, FDA also alerted health care providers to a shortage of tracheostomy tubes, used to help people breathe after a tracheotomy, including a tube made by ICU Medical for pediatric patients. The agency recommends providers and other caregivers consider using certain conservation strategies.
 
 

Related News Articles

Headline
FDA to limit COVID-19 vaccine to people over 65, others at high risk for serious illness
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
Recall issued for aspiration system by Q’Apel Medical
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
Study finds driving with COVID-19 raises crash risk by 25%
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
FDA issues alerts on certain catheters produced by BD, Conavi
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
FDA recalls Medtronic Aortic Root Cannulas 
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…